The longevity sector saw strong momentum over the past few months, with over $5.5 billion in funding spanning home-based care, breakthrough therapeutics, and AI-powered health solutions. Investors doubled down on aging-in-place technologies including senior care platforms, Medicare advocacy services, and brain-penetrating Alzheimer’s treatments. Policy developments supported this trend, with the Trump Administration unveiling plans to accelerate clinical AI deployment through a 3-year FDA approval pathway and Congress extending critical telehealth and diabetes prevention programs through 2030.